Intentional and non-intentional drug-related deaths

Auditorium IV
In programme
Friday, 25 October, 2024 - 10:50 to 12:20
View presentations

About

This session will address factors influencing intentional and accidental drug-related fatalities including adverse childhood experiences, psychiatric conditions, and prevalence Benzodiazepine.

Chair

Dietze
Paul
Professor and co-Director, Disease Elimination Program
Burnet Institute
 Melbourne , Australia
Trayner
Kirsten
Research Fellow/Epidemiologist
Glasgow Caledonian University/Public Health Scotland

Type

Oral presentation session

Tracks

Hepatitis C, other infectious diseases, and drug-related harms

Keywords

Quantitative methods
Overdose
Youth/children
Opiates
Public health
Mental health and wellbeing
Harm reduction
Europe
Prescription drugs
Toxicology and forensic analysis

Presentations

Friday, 25 October

10:50

Oral presentation

Accidental versus intentional drug overdose deaths: a national register linkage study

10:50 to 12:20
Auditorium IV
Rebecca McDonald

Oral presentation

Drug-induced deaths and non-fatal poisonings in youth – associations with ACE and psychiatric morbidity

10:50 to 12:20
Auditorium IV
Karoliina Karjalainen

Oral presentation

Prevalence of Benzodiazepine Prescription Prior to Overdose Deaths Compared to Toxicological Findings

10:50 to 12:20
Auditorium IV
Anna Armika Tussilago Nyman

Oral presentation

Suicide in people prescribed opioid-agonist therapy (OAT) in Scotland, 2011-2020: a national retrospective cohort study.

10:50 to 12:20
Auditorium IV
Rosalyn Fraser
View the programme